Vaccines Receives an Increased CiteScore of 9.9
26 June 2025
We are pleased to share that Vaccines (ISSN: 2076-393X) has received an increased CiteScore of 9.9 in June 2025.
Vaccines’ CiteScore ranks as follows:
- Q1 (24 out of 275) in the “Pharmacology (medical)” category;
- Q1 (36 out of 357) in the “Infectious Diseases” category;
- Q1 (39 out of 321) in the “Pharmacology” category;
- Q1 (25 out of 156) in the “Drug Discovery” category;
- Q1 (47 out of 240) in the “Immunology” category.
You can find more statistics on our website.
The current CiteScores measure the average number of citations within a journal over a four-year window (2021–2024). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.
This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Vaccines and its growing impact in laboratory and clinical vaccine research, utilization and immunization.